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• Schizophrenic patients show higher complexity values as compared to controls. • Schizophrenic 
patients showed a tendency to reduced complexity values as a function of age while controls showed 
the opposite tendency. • The tendency observed in schizophrenic patients parallels the tendency 
observed in Alzheimer disease patients. 
A B S T R A C T 
Objective: The neurodevelopmental-neurodegenerative debate is a basic issue in the field of the neuro-
pathological basis of schizophrenia (SCH). Neurophysiological techniques have been scarcely involved in 
such debate, but nonlinear analysis methods may contribute to it. 
Methods: Fifteen patients (age range 23-42 years) matching DSM IV-TR criteria for SCH, and 15 sex- and 
age-matched control subjects (age range 23-42 years) underwent a resting-state magnetoencephalo-
graphic evaluation and Lempel-Ziv complexity (LZC) scores were calculated. 
Results: Regression analyses indicated that LZC values were strongly dependent on age. Complexity 
scores increased as a function of age in controls, while SCH patients exhibited a progressive reduction 
of LZC values. A logistic model including LZC scores, age and the interaction of both variables allowed 
the classification of patients and controls with high sensitivity and specificity. 
Conclusions: Results demonstrated that SCH patients failed to follow the "normal" process of complexity 
increase as a function of age. In addition, SCH patients exhibited a significant reduction of complexity 
scores as a function of age, thus paralleling the pattern observed in neurodegenerative diseases. 
Significance: Our results support the notion of a progressive defect in SCH, which does not contradict the 
existence of a basic neurodevelopmental alteration. 
1. Introduction 
Schizophrenia (SCH) is a serious psychiatric disorder with a 
range of "positive" symptoms including paranoia, delusions and 
hallucinations, as well as "negative" symptoms such as cognitive 
impairment, flattened affect and disorganised thinking. Symptoms 
most commonly present in late adolesence in males and somewhat 
later in females, and the first psychotic episode is commonly pre-
ceded by a "prodromal" phase of progressively more severe symp-
toms which can last months or years. 
Clinically, it is a common observation that a functional decline 
starts around the t ime of the late prodromal phase or around the 
first psychotic episode (Tully and McGlashan, 2006), suggesting 
that a neurodegenerative process may be at the core of SCH. How-
ever, this neurodegenerative perspective has been challenged by 
the so-called neurodevelopmental theory (Murray and Lewis, 
1987; Rapoport et al., 2005) which considers SCH as the product 
of a deviation in neurodevelopmental processes that occurs before 
the onset of clinical symptoms (Rapoport et al., 2005). The neuro-
developmental vs. neurodegenerative debate is therefore a basic is-
sue in the biology of SCH. 
Magnetoencephalography (MEG) has been widely used in SCH 
research. MEG studies have replicated the well-known pattern of 
fronto-temporal low-frequency activity observed in EEC, and have 
also demonstrated abnormal sensory gating and basic cognitive 
processing (Canive et al., 1996; Kissler et al., 2000; Fehr et al., 
2003; Wienbruch et al., 2003; Edgar et al., 2005; Lopez-Ibor 
et al., 2008; Naatanen and Kahkonen, 2009). A further step in this 
research is non-linear dynamics analysis (NDA). Complexity analy-
sis is a particular form of NDA as applied to human brain activity, 
e.g. as measured using electroencephalography (EEC) or magneto-
encephalography (MEG). EEG-MEG complexity analyses usually 
measure the regularity/predictability of brain oscillations and/or 
attempt to estimate the number of independent oscillators under-
lying the observed signal (Lutzenberger et al., 1995; Jeong et al., 
1998). Numerous complexity measures have been proposed (see 
Tononi et al., 1998) including: dimensional complexity, algorith-
mic complexity, neural complexity, fractal dimension, first Lyapu-
nov component, correlation dimension, Lempel-Ziv Complexity 
(LZC), etc. (Elbert et al., 1992; Koukkou et al., 1993; Jeong et al., 
1998; Kim et al., 2000; Kotini and Anninos, 2002; Li et al., 2008). 
For example, the dimensional complexity refers to the classical 
method of the so-called correlation dimension. The algorithmic 
or Kolmogorov complexity is defined as the length of the string 
shortest description in some fixed description language. Finally, 
the neural complexity is a statistical measure that captures regu-
larities based on the deviation from independence among subsets 
of a system. In our study we have used the LZC, a measure for finite 
sequences that assigns larger values to more complex data (Lempel 
and Ziv, 1976). LZC is an appropriate measure of complexity in Kol-
mogorov's sense. 
Previous studies of neural activity complexity have provided 
somewhat contradictory results, with increased or decreased com-
plexity values seen in SCH patients, depending upon the character-
istics of the patient sample and the particular complexity 
parameter utilised. However, many studies revealed a pattern of 
increased complexity values, especially in frontal areas, in SCH pa-
tients (Elbert et al., 1992; Saito et al., 1998; Na et al., 2002; Irisawa 
et al., 2006; Li et al., 2008). This may be related to the increased 
"irregularity" of SCH patients' behaviour (Koukkou et al., 1993). 
Interestingly, according to Anokhin et al. (1996) and Meyer-Lin-
denberg (1996), there is an association between brain maturation 
and complexity scores, with a brisk increase of EEC complexity 
from childhood to early adolescence, and a further sustained in-
crease from adolescence to late adulthood. Thus "normal" brain 
development seems to be characterised by an increase of complex-
ity scores, at least until early senescence (Fernández et al., 2010). 
However, Fernández et al. (2009) found that this normal pattern 
of increasing complexity with age is absent in attention deficit-
hyperactivity disorder (ADHD), a disease with clear neurodevelop-
mental components (Shaw et al., 2007). In order to further investi-
gate the possible involvement of abnormal complexity in 
neurodevelopmental disorders, we therefore decided to measure 
LZC scores in a group of SCH patients and healthy controls. Our 
objective was twofold; first we tested a potentially abnormal pat-
tern of complexity evolution as a function of age in SCH patients. 
Subsequently, the pattern of increased complexity in SCH was 
tested. 
2. Methods 
MEG epochs were analysed by means of LZC. LZC is a measure of 
finite sequences and is essentially a measure of the number of dis-
tinct substrings and the rate of their occurrence along the sequence 
(Lempel and Ziv, 1976). (Aboy et al. (2006) investigated the factors 
that affects LZC and concluded that LZC represents an estimate of 
the number of different frequency components that actually com-
pose the brain signals. See the Appendix A for details of the 
analysis. 
2.1. Subjects 
Fifteen right-handed patients receiving care at the San Carlos 
University Hospital Institute of Psychiatry and Mental Health, 
who fulfilled the DSM-IV diagnostic criteria for SCH, were included 
in the study. Diagnosis was made with the Spanish version of the 
SCID-I (First et al., 1997). In order to obtain a homogeneous sample, 
we only included patients exhibiting a high degree of positive psy-
chotic symptoms. The Scale for the Assessment of Positive Symp-
toms (SAPS) (Andreasen, 1984) was used to evaluate positive 
symptoms of schizophrenia. According to a previous study (Lo-
pez-Ibor et al., 2008), a minimum score of 70 (of a maximum of 
165), and a minimal score of 29 (of maximum of 65) in the delu-
sional activity subscale, were required to enter in the study. 
The control group consisted of fifteen right-handed sex- and 
age-matched control subjects with no history of psychiatric disor-
der (Table 1). Subjects with a history of neurological diseases, head 
trauma, or drug abuse were excluded from the study. Conse-
quently, the data set consists of 30 sex- and age- jointly matched 
case-control pairs. 
Patients matching the above described criteria were consecu-
tively submitted to MEG scans. At the time of the study, all of 
the schizophrenic patients were using atypical antipsychotic med-
ication. In addition, two were on the typical antipsychotic haloper-
idol. Table 1 shows the dose equivalent of the medications and the 
duration of the illness. Prior to MEG recording, all subjects pro-
vided informed consent after being informed as to the technical 
and ethical considerations of the research. The study was approved 
by the ethics committee of the San Carlos University Hospital in 
Madrid. This sample has been partially described elsewhere (Lo-
pez-Ibor et al., 2008). 
2.2. Data collection 
MEG recordings were acquired with a 148-channel whole-head 
magnetometer (MAGNES 2500 WH®, 4D Neuroimaging, San Diego, 
CA) placed in a magnetically shielded room at "Centro de Magnet-
oencefalografía Dr. Pérez-Modrego" (Madrid, Spain). Subjects were 
in an awake but resting state with their eyes closed and under 
supervision during the recording. They were asked to avoid blink-
ing and making movements. For each subject, five minutes of MEG 
signal were acquired at a sampling frequency of 678.17 Hz using a 
hardware band-pass filter of 0.1-200 Hz. Afterwards, these record-
ings were down-sampled by a factor of 4 (169.549 Hz, 50863 sam-
ples). This process consisted of filtering the data to avoid aliasing 
(Nyquist criterion) and downsampling the recordings. The anti-ali-
asing filter was a second-order Butterworth IIR routine applied to 
the signals in both forward and reverse directions to avoid net 
phase shift with cut-off frequency at 76.30 Hz (45% of the final 
sample rate: 169.549 Hz). 
Artifact-free epochs of 20 s were selected off-line by a techni-
cian who was blind to diagnosis (mean = 13.7 artifact-free epochs 
per channel and subject). Of note, no significant differences in 
terms of artifact-free epochs were found between patients and 
controls. Finally, all epochs were filtered between 1.5 and 40 Hz, 
and copied to a computer as ASCII files for further complexity 
analysis. 
2.3. Lempel-Ziv complexity calculation 
LZC analysis is based on a coarse-graining of measurements. 
Therefore, the MEG signal must be previously transformed into a 
Table 1 
Characteristics of the sample (meants.d.; min-max where applicable), n.a.: not 
applicable. 
Sex 
Age (years) 
Length of illness (years) 
Haloperidol equivalent dose 
(mg) 
Lorazepam equivalent dose 
(mg) 
SAPS scores Total 
Delusions 
Patients 
15; 1 1 M . 4 F 
31.93 ±6.60; 23-42 
5.58 ±3.20; 1-9 
33.00 ±19.02; 7-62 
1.74 ±1.70; 0-4.5 
89.38 ±13.71; 72.00-
117.0 
40.77 ±8.09; 29-51 
Controls 
15; 1 1 M . 4 F 
31.87 ±6.02; 2 3 -
42 
n.a. 
n.a. 
n.a. 
n.a. 
2.4. Data reduction 
A LZC-normalised score was obtained for each channel and par-
ticipant, calculating the mean value over all the 20-s artifact-free 
epochs. Thus there were a total of 148 LZC scores per subject avail-
able for statistical analysis. In order to avoid the multiple-compar-
isons problems posed by this amount of data, the 148 channels 
were grouped into five regions (anterior, central, left lateral, right 
lateral, and posterior), and the mean LZC value for each region 
was calculated (see Fig. 1). This approach has been successfully uti-
lised previously (Fernández et al., 2009, 2010). 
2.5. Statistical analysis 
finite symbol string. In this study we used the simplest possible 
way: a binary sequence conversion (zeros and ones). By compari-
son with a threshold Id, the original signal samples are converted 
into a 0-1 sequence P = s(l), s(2) s(n), with s(¡) defined by 
(Zhang et al., 2001): 
s(i) 0 ifx(i)<Td 1 ifx(i)^Td (1) 
The threshold Td is estimated as the median value of the signals 
amplitude in each channel. We selected the median value because 
it is more robust to outliers (Nagarajan, 2002; Zhang et al., 2001). 
The string P is then scanned from left to right and a complexity 
counter c(n) is increased by one unit every time a new subse-
quence of consecutive characters is encountered in the scanning 
process. The detailed algorithm for the measure of the LZ complex-
ity is included in Apendix A. 
Two-sample t-tests were applied to evaluate LZC differences be-
tween the groups. 
Pearson correlation coefficients were used to examine the rela-
tionship among LZC scores between regions in both groups. This 
analysis offers a hint about a potential variable reduction process 
when the analysis of the prognostic importance of LZC scores is 
undertaken. Correlations between LZC scores and clinical variables 
were assessed using the Spearman's correlation coefficient. 
In order to avoid the potential confounding influence of age, the 
relationship between age and LZC scores was investigated by 
means of linear regression analyses in the two groups in each of 
the five regions. 
Logistic regression analyses were applied with "Diagnosis" as a 
dependent variable in order to ascertain whether neural complex-
ity scores could act as predictors of diagnosis. The independent (or 
predictor) variables initially considered were the LZC scores ob-
tained for each region. The model's performance was assessed by 
means of classification tables, together with standard Hosmer 
and Lemeshow (1989) goodness of fit tests, and the Nagelkerke 
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Fig. 1. Sensor-space representation of the five regions submitted to statistical analyses, both for LZC and MF values: anterior, central, left lateral, right lateral and posterior. 
R2 goodness of fit statistics. The efficiency of the final models was 
assessed by the area under the receiver operating characteristic 
(ROC) curve, together with the usual goodness of fit tests. 
3. Results 
3.1. LZC differences between groups 
The means and standard deviations of the LZC scores for SCH 
and control groups in each of the five regions are shown in Table 2 
which also shows the between-group differences in terms of Co-
hen's d effect sizes (Cohen, 1988). SCH patients' LZC values were 
greater than those of the controls in all brain regions (see also 
Fig. 2). I-tests showed statistically significant (p < 0.05) differences 
in all regions with the exception of the posterior region where a 
close-to-significant trend was observed (p = 0.071). For comparison 
purposes, a conventional spectral analysis was also performed in 
order to evaluate the characteristics of MEG signals (see Fig. 3). 
3.2. Correlation analysis 
LZC scores in each region showed a strong linear correlation 
with the LZC scores in each other region, in both groups. All corre-
lation coefficients, except the anterior-posterior and central-pos-
terior correlations, were over 0.80, with the central, anterior left 
lateral and right lateral regions being the most strongly correlated 
regions. 
However, no significant non-parametric correlation was found 
among LZC scores and the clinical variables using non-parametric 
analyses: SAPS total score (p>0.27), length of illness (p>0.10), 
and medications in terms of dose equivalents, lorazepam equiva-
lents (p > 0.31) and haloperidol equivalents (p > 0.61) (see Table 3). 
"Diagnosis" (schizophrenia or control). The independent (predic-
tor) variables initially consisted of the five regional LZC scores. 
In a preliminary univariate analysis, all LZC scores showed a po-
sitive predictive power (all likelihood ratio tests showed a 
p < 0.05). In a multivariate analysis, including all LZC scores, a step-
wise procedure selected the central region ( ^ = 7.401, p = 0.007) 
as a significant predictor for the final model. 
In the light of the results discussed above regarding age, the 
model was refitted including age as an additional variable. This 
model showed no significant improvement over the previous mod-
el excluding age ( ^ = 0.219, p = 0.640), showing that age per se 
adds little once central LZC value has been included. This result 
was expected because age is a matching variable. However, Fig. 4 
shows very different behaviour of LZC values as a function of age, 
suggesting that age acts as a modifier rather than as a confounding 
effect and that age should be tested in terms of an age x central 
LZC interaction. 
The model-building process continued by ascertaining the cor-
rect scale in the Logit for age and central LZC variables. This anal-
ysis showed evidence of linearity in both cases. Finally we searched 
for an age x central LZC interaction. The interaction was strongly 
significant ( ^ = 17.331, p = 0.001). Thus, age has a modifier effect. 
Therefore this model including central LZC score, age and the 
age x center LZC interaction was selected as the best model for 
SCH-Control discrimination. The Hosmer and Lemeshow statistic 
was 4.265 (p = 0.832) and the Nagelkerke R2 goodness of fit statis-
tic was 0.753, indicating that 75.3% of the "variation" in the diag-
nosis (SCH vs. control) was explained by the logistic model. The 
area under the ROC (see Fig. 5) curve was 0.956 (95% CI = 0.886; 
1.000). The sensitivity and specificity of model was 86.7% when a 
0.50 cut-off point is adopted (two misclassified subject in each 
diagnostic group). 
3.3. Age effects 4. Discussion 
The relationship between age and LZC scores was investigated 
by means of linear regression analyses in the two groups. In the 
SCH patients, a negative trend was observed, indicating a tendency 
for decreased LZC scores with increasing age in all regions. More-
over, this effect was statistically significant, according to a linear 
regression t-test, in all regions (all p < 0.008), with all correlation 
coefficients r at least -0.67. 
By contrast, in the control group, the opposite pattern emerged: 
LZC was positively correlated with age. This trend was clearly sig-
nificant in the central (p = 0.01 and r = 0.641), anterior (p = 0.001 
and r = 0.828) and posterior (p = 0.014 and r = 0.620) regions, and 
was close to significant in the right lateral (p = 0.052, r = 0.511) 
and left lateral (p = 0.058, r = 0.500) regions (see Fig. 4). 
3.4. Logistic regression analyses 
We fitted a series of logistic regression equations to obtain a 
model to discriminate between the SCH and control groups on 
the basis of their LZC scores. The dependent variable was 
Our data show that compared to healthy controls, patients with 
schizophrenia have more complex resting-state neural activity. 
Neural activity was assessed using MEG and complexity was calcu-
lated in terms of LZC scores. While SCH patients showed increased 
complexity across the brain, the increase was especially marked 
over central cortical regions. 
Furthermore, we observed that LZC values are strongly depen-
dent on age, but that the direction of the relationship was reversed 
in schizophrenic patients as opposed to healthy people: in controls 
complexity increased with age but in patients it decreased with 
age. A logistic model was able to predict group assignment (diag-
nosis) on the basis of individual LZC scores and ages. Our findings 
partially support prior reports (Elbert et al., 1992; Na et al., 2002; 
Irisawa et al., 2006; Li et al., 2008) of increased complexity values 
in SCH, however unlike previous investigators we also investigated 
the effects of age. 
Like all complexity measures, LZC is essentially an estimate of 
the predictability and variability of neural signals in terms of fre-
quency components (see Introduction). However, LZC has advanta-
Table 2 
Region x group comparisons of LZC values between SCH and control groups. The table includes results of t-tests, probabilities and effect sizes. 
sz 
Control 
t-Statistic 
p-Value 
Effect sizes 
Mean 
SD 
Mean 
SD 
Central 
0.7312 
0.0309 
0.6936 
0.0309 
2.888 
0.007 
1.217 
Anterior 
0.7198 
0.0382 
0.6911 
0.0265 
2.387 
0.024 
0.873 
Right lateral 
0.6852 
0.0428 
0.6524 
0.0308 
2.408 
0.023 
0.879 
Left lateral 
0.6813 
0.0400 
0.6503 
0.0306 
2.385 
0.024 
0.871 
Posterior 
0.6755 
0.0424 
0.6473 
0.0398 
1.877 
0.071 
0.686 
Controls 
<jg) <SD <@) 
'.Asa; Á63>Í7S>(SSS 
4 i # <65Í> <sg> * ^ 
Patients 
12 
^ ^ ^ ^ ^ ^ • • • ^ ^ ^ ^ ^ 
(S3> ;A70ÍA5^A35;S^19ÍSXA3.XA1PJA25. . Á44J ASSESS
1
 (gjj^ 
FcS£. 
<SS>
 ( g g ) <S# 'Sis* <©> 
A1A 
<gTg> 
0.56 0.58 0.6 0.62 0.64 0.66 0.68 
I I I 
1 1 ! 1 
0.7 0.72 0.74 
Fig. 2. Average LZC values in patients with SCH and control subjects for all channels, from Al to A148, displayed in a colour scale. A significant increase of LZC values is 
observed in SCH. Sample size, SCH patients = 15, controls = 15. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of 
this paper.) 
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Fig. 3. Mean relative power spectra for all channels in schizophrenia and control groups. This figure illustrates the slowing of alpha peak in schizophrenia patients. 
Table 3 
Spearman's rank correlation coefficients, and their p-values, displaying correlations between LZC scores and the clinical variables: SAPS total score, duration of illness, and 
medications dose equivalent (lorazepam and haloperidol). 
SAPS total score 
Duration of illness 
Lorazepam dose equivalents 
Haloperidol dose equivalent 
Central 
-0.199 
p = 0.514 
-0.293 
p = 0.355 
0.320 
p = 0.310 
-0.165 
p = 0.609 
Anterior 
-0.329 
p = 0.272 
-0.494 
p = 0.103 
0.130 
p = 0.687 
-0.053 
p = 0.871 
Right lateral 
-0.025 
p = 0.936 
-0.304 
p = 0.336 
0.173 
p = 0.592 
-0.028 
p = 0.931 
Left lateral 
-0.077 
p = 0.801 
-0.233 
p = 0.467 
0.053 
p = 0.514 
0.158 
p = 0.625 
Posterior 
-0.177 
p = 0.563 
-0.336 
p = 0.285 
0.056 
p = 0.862 
0.126 
p = 0.696 
ges over traditional non-linear techniques such as the correlation of noise-free stationary data (Eckmann and Ruelle, 1992; Grassber-
dimension and the first Lyapunov exponent in terms of the analysis ger and Procaccia, 1983), the LZC is robust to noise and can be ap-
of MEG/EEG data. Whereas other methods require a large amount plied to both deterministic and stochastic time series (Lempel and 
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Fig. 4. Regression lines of LZC values versus age, plotted for the five regions. Black solid lines correspond to control group, and dotted black lines correspond to patients with 
SCH. "X" axis represents age values of patients and controls. Patients with SCH showed a significant tendency to reduced LZC scores as a function of age, while controls 
exhibited an opposite tendency. Sample size, SCH = 15, controls = 15. 
Ziv, 1976). As the median was used as threshold for the binary con-
version, LZC is also robust to outliers. Finally, Aboy et al. (2006) 
concluded that LZC is not affected by the power of white noise. 
Early electrophysiological studies of schizophrenia emphasised 
the so called "dysrhythmia" (Itil, 1977) in this disease. This was la-
ter described as a pattern of, on the one hand, increased frequency 
variability and, also, a reduced signal amplitude (Shagass et al., 
1982). It might be expected that brain signals derived from pa-
tients suffering from a disease that increases EEG-MEG variability 
should yield higher complexity values. In addition, the complexity 
of brain activity measured by EEG-MEG signals is considered to be 
intimately associated with the integrity of brain connectivity 
(Sporns et al., 2000; Jeong, 2004). Many researchers e.g. Friston 
(1996, 2002) have proposed that the fundamental pathology in 
SCH is a disconnection between functional regions of the brain, 
and that such dysconnectivity induces higher complexity values 
(Friston, 1996). See also (McGlashan and Hoffman, 2000). Dyscon-
nectivity may lead to symptom formation and explain the altered 
brain response to environmental stimuli (delusions and hallucina-
tions.) The misdistribution of connections in a system with low 
cognitive potential, limited reserve, and poor flexibility could be 
reduced by antipsychotic treatment in parallel with the attenua-
tion of psychotic symptoms (McGlashan, 2006). 
Our data are consistent with this account, but we were also able 
to demonstrate a novel finding, namely the divergent trajectory of 
complexity with age in patients and controls. Such abnormal mat-
urational processes have also been shown in structural investiga-
tions in schizophrenia. For example, Ho et al. (2003) performed a 
longitudinal study in a large sample of first-episode SCH patients 
and controls using MRI to measure white matter, grey matter 
and CSF volumes. They showed a progressive enlargement of 
white-matter volumes, especially in the frontal lobes, in healthy 
controls while in the SCH patients the reverse was true. The 
authors interpreted these findings as consistent with a failure to 
complete the "normal" maturational process of myelination. Other 
studies using other methods such as diffusion tensor imaging 
(Jones et al., 2006) have provided similar results. 
Considering these findings, and bearing in mind that the pro-
gressive loss of brain volume observed in some SCH samples is very 
similar to that observed in Alzheimer disease (AD) and other 
dementias (Krueger et al., 2010), it is difficult to maintain that 
schizophrenia is a purely neurodevelopmental condition. Post-
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Fig. 5. ROC curve of the logistic regression model based on age and centre LZC 
variables. 
mortem studies showing the absence of gliosis in schizophrenic 
brains has been considered a major argument against the idea that 
SCH is a neurodegenerative disease (Roberts et al., 1986,1987) but 
neurodegeneration does not necessarily imply gliosis: for example 
excessive neuritic pruning could account for progressive brain 
alterations such as a progressive reduction of brain volume 
(Woods, 1998; Lieberman et al., 2001; Perez-Neri et al., 2006; The-
berge et al., 2007). 
Do our results support the alternative view of a neurodegener-
ative process in SCH? Bearing in mind the limitations of this study 
(see below) it would be presumptuous to conclude that we have 
demonstrated a neurodegenerative process in SCH. Nevertheless, 
we claim our findings support a progressive defect which does 
not contradict the existence of a basic neurodevelopmental alter-
ation. In a previous study we (Fernández et al., 2010) observed a 
progressive reduction of LZC values as a function of age in AD. 
The present data indicate that: 1. SCH patients did not show the 
"normal" process of increasing complexity as a function of age, 
rather showing a reduction of complexity as a function of age, 
and 2. The same pattern was observed in AD patients. 
5. Significance 
A major limitation of our study was the fact that all patients 
were on medication, notably antipsychotics. Although there was 
no significant correlation between LZC and medication dosage-
equivalents, drug effects cannot be ruled out. Previously, Jeong 
et al. (1998) and Kim et al. (2000) likewise found no correlation be-
tween antipsychotic dose and complexity values. Nevertheless, 
authors were cautious when interpreting this absence of signifi-
cant correlations. Higher complexity values might be still partially 
attributed to drug effects although similar findings of increased 
complexity values were obtained in non medicated samples (Saito 
et al., 1998). 
Secondly, we utilised a cross-sectional rather than a longitudi-
nal design to investigate age effects. A longitudinal investigation 
of first episode patients and young populations at risk of develop-
ing SCH would be of great interest. Thirdly, our sample size was 
relatively small. 
Notwithstanding these limitations, our data suggest that the 
investigation of complexity in neural activity is a promising ap-
proach to understanding the neural basis of schizophrenia and 
other neuropsychiatric disorders. 
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Appendix A. Lempel-Ziv complexity algorithm 
The detailed algorithm for the measure of the LZ complexity is 
as follows (Zhang et al., 2001): 
(1) Let S and Q_ denote two subsequences of the original 
sequence P and SQ_ be the concatenation of S and Q, while 
SQn is a string derived from SQ_ after its last character is 
deleted (n means the operation to delete the last character). 
(2) Let tiSQn) denote the vocabulary of all different substrings 
ofSQre. 
(3) At the beginning, the complexity counter c(n) = 1, S = s(l), 
Q= s(2), SQ= s(l), s(2) and SQn = s(l). 
(4) In general, suppose that S = s( 1), s(2) s{r), Q_ = s(r + 1) and, 
therefore, SQn = s(l), s(2) s(r). If Q_e ksQn), then Q_ is a 
subsequence of SQn, not a new sequence. 
(5) S does not change and renew Q_ to be s(r + 1), s(r + 2), then 
judge if Q_ belongs to tiSQn) or not. 
(6) The steps 4 and 5 are repeated until Q_ does not belong to 
v{SQn). Now Q.= s(r + 1), s(r + 2) s(r + i) is not a subse-
quence of SQn = s(l), s(2) s(r + i —1), so increase the 
counter by one. 
(7) Thereafter, S and Q_ are combined and renewed to be s(l), 
s(2) s(r + ¡), and s(r + i + 1), respectively. 
(8) Repeat the previous steps until Qis the last character. At this 
time, the number of different substrings is c(n), the measure 
of complexity. 
In order to obtain a complexity measure which is independent 
of the sequence length, c(n) should be normalised. If the length 
of the sequence is n and the number of different symbols is a, it 
has been proved (Lempel and Ziv, 1976) that the upper bound of 
c(n) is given by: 
c(n) < (1 - £„)loga(n) (2) 
where en is a small quantity and en -> 0 (n -> oo). In general, n/lo-
ga(n) is the upper limit of c(n), where the base of the logarithm is 
a, i.e., 
lim 
c(n) = b(n) • 
loga(n) 
bin) 
For a binary conversion a = 2, and b(ji) is given by 
n 
log2(n) 
and c(n) can be normalised via b(n): 
c{n) 
C(n): b(n) 
(3) 
(4) 
(5) 
C(n) is usually a value between zero and one. The normalised 
LZC reflects the arising rate of new patterns along with the se-
quence (Zhang et al., 2001). A minimum data length must be con-
sidered to ensure that LZC reveals real data features (Yan and Gao, 
2004). Since a previous work showed that the LZC values become 
stable for MEGs longer than 3000 samples (Gómez et al., 2006), 
an epoch length of 3392 data points (20 s) was used in the current 
study. 
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